Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Porter

Showing results (101-110 of 159) with videos related to

Pageof 16
Sort By:
The Journal of Surgical Research|January 7, 2023
Trauma Incidence During the New Jersey COVID-19 Stay-At-Home Order: A Multicenter StudyJeremy M Badach, Rebecca Platoff, Deviney Rattigan, et al.
British Journal of Haematology|April 22, 2008
Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapyMaxwell Westerman, Arnold Pizzey, Jocelyn Hirschman, et al.
The Journal of Clinical Endocrinology and Metabolism|September 5, 2020
A Prospective Study of Children Aged 0-8 Years with CAH and Adrenal Insufficiency Treated with Hydrocortisone GranulesUta Neumann, Katarina Braune, Martin J Whitaker, et al.
Nature Communications|January 26, 2021
Structural insights into the disruption of TNF-TNFR1 signalling by small molecules stabilising a distorted TNFDavid McMillan, Carlos Martinez-Fleites, John Porter, et al.
British Journal of Haematology|October 3, 2006
Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell diseasePatrick B Walter, Ellen B Fung, David W Killilea, et al.
European Journal of Endocrinology|August 11, 2021
An oral lipidic native testosterone formulation that is absorbed independent of foodJohn Newell-Price, Hiep Huatan, Jo Quirke, et al.
Bioorganic & Medicinal Chemistry Letters|November 5, 2020
A highly potent maytansinoid analogue and its use as a cytotoxic therapeutic agent in gold nanoparticles for the treatment of hepatocellular carcinomaJohn Porter, Yao Ding, Sarah J M Hale, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2008
Tetrahydroisoquinoline amide substituted phenyl pyrazoles as selective Bcl-2 inhibitorsJohn Porter, Andrew Payne, Ben de Candole, et al.
European Journal of Endocrinology|January 27, 2018
Poor compliance and increased mortality, depression and healthcare costs in patients with congenital adrenal hyperplasiaSara Jenkins-Jones, Lotta Parviainen, John Porter, et al.
Haematologica|June 17, 2008
Safety and efficacy of pegylated interferon alpha-2a and ribavirin for the treatment of hepatitis C in patients with thalassemiaPaul Harmatz, Maureen M Jonas, Janet L Kwiatkowski, et al.
Pageof 16

Showing results (101-110 of 159) with videos related to

Sort By:
Pageof 16
The Journal of Surgical Research|January 7, 2023
Trauma Incidence During the New Jersey COVID-19 Stay-At-Home Order: A Multicenter StudyJeremy M Badach, Rebecca Platoff, Deviney Rattigan, et al.
British Journal of Haematology|April 22, 2008
Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapyMaxwell Westerman, Arnold Pizzey, Jocelyn Hirschman, et al.
The Journal of Clinical Endocrinology and Metabolism|September 5, 2020
A Prospective Study of Children Aged 0-8 Years with CAH and Adrenal Insufficiency Treated with Hydrocortisone GranulesUta Neumann, Katarina Braune, Martin J Whitaker, et al.
Nature Communications|January 26, 2021
Structural insights into the disruption of TNF-TNFR1 signalling by small molecules stabilising a distorted TNFDavid McMillan, Carlos Martinez-Fleites, John Porter, et al.
British Journal of Haematology|October 3, 2006
Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell diseasePatrick B Walter, Ellen B Fung, David W Killilea, et al.
European Journal of Endocrinology|August 11, 2021
An oral lipidic native testosterone formulation that is absorbed independent of foodJohn Newell-Price, Hiep Huatan, Jo Quirke, et al.
Bioorganic & Medicinal Chemistry Letters|November 5, 2020
A highly potent maytansinoid analogue and its use as a cytotoxic therapeutic agent in gold nanoparticles for the treatment of hepatocellular carcinomaJohn Porter, Yao Ding, Sarah J M Hale, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2008
Tetrahydroisoquinoline amide substituted phenyl pyrazoles as selective Bcl-2 inhibitorsJohn Porter, Andrew Payne, Ben de Candole, et al.
European Journal of Endocrinology|January 27, 2018
Poor compliance and increased mortality, depression and healthcare costs in patients with congenital adrenal hyperplasiaSara Jenkins-Jones, Lotta Parviainen, John Porter, et al.
Haematologica|June 17, 2008
Safety and efficacy of pegylated interferon alpha-2a and ribavirin for the treatment of hepatitis C in patients with thalassemiaPaul Harmatz, Maureen M Jonas, Janet L Kwiatkowski, et al.
Pageof 16